Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue
1 other identifier
observational
10
1 country
1
Brief Summary
This is a laboratory-based, exploratory study using tissue obtained from our clinical practice. The purpose of this study is to confirm our ability to characterize miR expression in various tissues (proximal and distal esophagus, stomach and duodenum) obtained from the upper gastrointestinal tract in preparation for the study of MiR in patients with Barrett's esophagus and other inflammatory conditions of the upper gastrointestinal tract.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2008
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 27, 2009
CompletedFirst Posted
Study publicly available on registry
May 28, 2009
CompletedFebruary 12, 2015
February 1, 2015
7 months
May 27, 2009
February 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
miR expression between tissue from Barrett's esophagus and that from normal tissues
time it takes to have standard of care biopsies taken during one routine Upper Endoscopy
Secondary Outcomes (1)
expression of miR in Barrett's esophagus patients with cancer in comparison to those who do not progress to cancer
time it takes to have standard of care biopsies during one routine Upper Endoscopy
Study Arms (1)
No treatment
genetic research project; to meet inclusion criteria, participants must have normal upper GI tract upon upper endoscopy, for study biopsies to be taken
Eligibility Criteria
Study subjects identified from individuals referred for upper endoscopy at Mayo Clinic in Jacksonville, Florida
You may qualify if:
- willingness to give consent
- normal gross appearance of the esophagus, stomach and duodenum
You may not qualify if:
- contraindication to mucosal biopsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Jacksonville, Florida, 32224, United States
Biospecimen
biopsy tissue from proximal and distal esophagus, stomach and duodenum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth R. DeVault,, M.D.
Mayo Clinic, Jacksonville, Florida
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair, Department of Medicine, Mayo Clinic, Jacksonville Florida
Study Record Dates
First Submitted
May 27, 2009
First Posted
May 28, 2009
Study Start
April 1, 2008
Primary Completion
November 1, 2008
Study Completion
November 1, 2008
Last Updated
February 12, 2015
Record last verified: 2015-02